Novel uses of combined selective dopamine d2 receptor antagonists and 5-ht receptor agonists

摘要

Use of compounds being combined selective dopamine D2 receptor antagonists and 5-HT_1A receptor agonists, in particular (R)-()-2-5-4 fluorophenyl)-3-pyridylmethyl-aminomethyl-chromane or a physiologically acceptable salt thereof or N-(4-fluoro-3-biphenylmethyl)-N-2-(3-cycanophenoxy-ethyl)-amine or a physiologically acceptable salt thereof, for the manufacture of a medicament for use in veterinary medicine for the treatment of self directed traumatic disorders associated with behavioral stressors, compulsive disorders associated with behavioral stressors and/or anxiety disorders associated with behavioral stressors.